Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05600946 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Characterization of Dysmorphology in Subjects With Creatine Transporter Deficiency

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Sep 1, 2026 → Sep 1, 2027
See other at-risk trials from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Sep 1, 2026 to Sep 1, 2027
    • Eligibility criteria expanded, about 8 words
  2. Notable Enrollment increased: 19 → 30 participantsv17
  3. Minor Re-verified, no change to tracked fieldsv16
  4. Notable Primary and study completion dates: Sep 1, 2025 to Sep 1, 2026v15
  5. Minor 8 versions Re-verified since Sep 7, 2024, no change to tracked fieldsv7-v14
Show 5 earlier versionsHide 5 earlier versions
  1. Minor Study description shortened, about 1 wordv6
  2. Minor 2 versions Re-verified since Jan 20, 2023, no change to tracked fieldsv4-v5
  3. Minor Start date changed from estimate of Nov 7, 2022 to Oct 24, 2022v3
  4. Minor Start date: Nov 6, 2022 to Nov 7, 2022v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Creatine transporter deficiency (CTD) is a genetic disorder that mainly affects the brain in males. CTD causes intellectual disability that can be mild to severe. People with CTD may have seizures and behavioral issues. They may have slow growth and tire easily. CTD may sometimes be confused with autism or other disorders. Better diagnostics are needed. The study team in an NIH study noted that the faces of children with CTD can look similar. For this natural history study, an expert will examine photos of children with CTD. Any shared traits found might help to diagnose CTD. Objective: To look for shared facial features of children with CTD. Eligibility: Males aged 2 to 40 years old with CTD who were in study 17-CH-0020. Design: Some participants in study 17-CH-0020 had pictures taken of their faces. The NIH study team wants to share these photos with a colleague in Canada. This person is an expert at evaluating how genetic disorders affect people s bodies. Participant data collected during the study may also be sent to this expert. This data may include diagnostic images and results from lab tests. Some children did not have their pictures taken during study 17-CH-0020. Parents are asked to take pictures of these children and send them to the study team. These photos can be sent to a secure portal. The photos can also be taken in-person during a clinic visit. The photos may be printed in clinical study journals. But this is not required. Parents will be asked to sign a separate consent before the photos are published....
Trial Details
NCT Number NCT05600946
Lead Sponsor Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborators: McMaster University, Ontario, Canada
Conditions
(from sponsor)
Cognitive Disorder, Metabolic Disease, Autism Spectrum Disorder
Related terms Autism Spectrum Disorder, Cognitive Dysfunction, Learning Disabilities, Metabolic Diseases
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov